A platform for CRISPRi-seq in Streptomyces albidoflavus
ABSTRACT Streptomyces produce a multitude of secondary metabolites, which have been exploited in drug discovery campaigns for more than three-quarters of a century. Our understanding of microbial physiology has been revolutionized by genome sequencing and large-scale functional studies. Technology f...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology
2026-02-01
|
| Series: | mBio |
| Assuntos: | |
| Acceso en liña: | https://journals.asm.org/doi/10.1128/mbio.03065-25 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|